A) Scanning electron microscopy of implant nanoscale channels controlling drug release, B) Design [...]
A number of UW Bioengineering faculty members quickly pivoted and are adapting their research to addressing the needs created by the coronavirus pandemic. From developing rapid at-home tests and protective masks to vaccines and treatments, here is a sampling of some of the ways UW BioE faculty, staff and students are stepping up to help.
Online Master of Pharmaceutical Bioengineering prepares working professionals to drive drug discovery, development
In this professional master's degree program, students gain cutting-edge knowledge in basic bioscience, drug discovery and pharmaceutics, and learn how to apply their expertise to market-based demands of pharmaceutical industry.
UW Bioengineering faculty James Lai, Suzie Pun and Patrick Stayton, and BioE Ph.D. alumnus and affiliate faculty member Patrick Hsieh, are among contributing authors of a paper describing a novel treatment for limb ischemia.
Patrick Stayton, the Distinguished Career Professor of Bioengineering and director of the UW Molecular Engineering and Sciences Institute, and Valerie Daggett, professor of bioengineering, will present 2016-2017 UW Medicine Science in Medicine Lectures.
Boldly pursuing the forefront of molecular engineering and nanotechnology, Patrick Stayton embodies UW Bioengineering’s mission to invent the future of medicine.
Medical test and drug development technologies from UW Bioengineering have spun out into start-ups Nexgenia and Nanosurface Biomedical, with Coulter's help.
“Big Potential in Going Small”: Patrick Stayton’s nanotechnology research mentioned in Alaska Airlines Magazine
“Big Potential in Going Small”: Patrick Stayton’s nanotechnology research mentioned in Alaska Airlines Magazine. The article explores the history of nanotechnology, its current application and Dr. Stayton’s current work developing a nanotechnology delivery system to treat certain diseases, including liver cancer.
UW researchers, including BioE Professor Patrick Stayton and many collaborators from the UW and Fred Hutchinson Cancer Research Center, have created a protein molecule that can prompt cancer cells infected with the Epstein-Barr virus to self-destruct.
Seattle hosted the 2013 BMES Annual Meeting, and UW Bioengineering student, faculty and staff volunteers were present in force to welcome, engage and educate over 4,000 conference attendees.
UW Bioengineering professors David Castner, Paul Yager and Patrick Stayton named to Washington State Academy of Sciences.